Interventional Oncology Devices | Market Insights | US | 2023
Despite the short-term challenges posed by the COVID-19 pandemic, the US market for interventional oncology devices will grow moderately through 2031. This will be driven largely by the expanding treatable patient populations, an increasing shift towards higher-priced technologies such as radioembolization, and growing physician acceptance of interventional oncology procedures.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in the US from 2019 through 2031.
